Guggenheim Initiates Coverage On Cidara Therapeutics With Buy Rating, Announces Price Target of $33
Guggenheim Initiates Coverage On Cidara Therapeutics With Buy Rating, Announces Price Target of $33
古根海姆開始對cidara therapeutics進行買入評級,宣佈目標價爲33美元
Guggenheim analyst Seamus Fernandez initiates coverage on Cidara Therapeutics (NASDAQ:CDTX) with a Buy rating and announces Price Target of $33.
古根海姆分析師Seamus Fernandez發起對cidara therapeutics(納斯達克:CDTX)的覆蓋,給予買入評級,並宣佈目標股價爲33美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。